[1]Patent:WO2011/12622,2011,A1.Locationinpatent:Page/Pagecolumn104
[2]Tetrahedron,2012,vol.68,p.9795-9801,7
[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2011/12622,2011,A1
39793-31-2
121933-59-3
897921-59-4 | N-[4-(1-Naphthyl)phenyl]-4-biphenylamine | AA00H2P3 | MFCD11112864
903556-85-4 | 5-(Aminomethyl)benzo[d]oxazol-2(3H)-one hydrochloride | AA00H30L | MFCD20278305
875644-71-6 | 5-(bromomethyl)-3-methyl-1,2,4-oxadiazole | AA00H3SV | MFCD20485097
910543-72-5 | 3-Amino-5-bromo-1-methylpyridin-2(1H)-one | AA00H4O5 | MFCD09835082
934606-33-4 | N-hydroxycycloheptanecarboxamidine | AA00H5FS | MFCD22413666
98010-71-0 | 3H-1,2,4-Triazole-3-thione, 2,4-dihydro-4-(2-propenyl)-5-pyrazinyl- | AA00H6K3 | MFCD02258401
93882-12-3 | 8-CPT-cAMP | AA00H8GF | MFCD00057683
100219-61-2 | 1-(Hydroxymethyl)-1h-pyrazole-3-carboxylic acid | AA00H93Z | MFCD04969814
1015846-42-0 | 1-[1-(4-Morpholinylmethyl)cyclopropyl]methanamine | AA00H9FD | MFCD09971242
1029718-68-0 | 5-Chloro-3-(3-fluorobenzyl)-1,2,4-thiadiazole | AA00H9TN | MFCD14707331